Amplified peptide proven to extend effects of cosmetic injections

New data reveals that Argireline® Amplified peptide has the ability to extend the anti-wrinkle effects of cosmetic injections.

Lubrizol, a global leader in speciality chemicals, is excited to announce the results of a groundbreaking clinical study. The study demonstrates that a combination of Argireline® Amplified peptide and Botulinum toxin type-A (BTA) injections can effectively keep wrinkles at bay for nearly eight weeks longer than BTA alone. This naturally derived peptide not only enhances but also prolongs the anti-ageing effects of cosmetic injections, providing a more enduring solution for wrinkle reduction.

Argireline® Amplified peptide is an evolution of the globally renowned Argireline® peptide. Designed in line with the principles of Green Chemistry, it boasts superior in vitro activity and added muscle relaxation effects compared to the original Argireline® peptide. Initially used in topical treatments as a non-invasive alternative to reduce facial muscle activity, Argireline® Amplified peptide is clinically proven to significantly extend the effects of BTA injections when used in combination.

Superior results with peptide combination

In the recent study, 45 Caucasian volunteers, both male and female, aged between 35 and 60, received 50 UI Botulinum toxin type A injections in the crow’s feet, frown lines and forehead areas. They also applied a cream containing 5% Argireline® Amplified peptide solution or a placebo cream to their entire face twice daily for four months. Researchers used 2D and 3D facial imaging to monitor changes in wrinkle visibility, skin roughness, and wrinkle length in areas such as crow’s feet, frown lines and the forehead.

Results showed that after one, three and four months, participants who received the active peptide combination treatment exhibited significantly fewer wrinkles compared to those who received BTA and a placebo. This combination treatment extended the wrinkle-free period by almost eight weeks longer than BTA alone.

The synergy between BTA and Argireline® Amplified peptide meets the growing demand for effective, longer-lasting dermo-aesthetic solutions, allowing consumers to make fewer trips to the clinic and spend more time enjoying the benefits of smooth, youthful skin. Argireline® Amplified peptide is available in South Africa from Savannah Fine Chemicals, an approved distributor of Lubrizol.